Novel Peroxisome Proliferator Activated Receptor–α Agonists

This publication has 14 references indexed in Scilit:

• Peroxisome Proliferator-Activated Receptors at the Crossroads of Obesity, Diabetes, and Cardiovascular Disease
  Journal of the American College of Cardiology, 2006
• Transcriptional regulation of macrophage cholesterol trafficking by PPARα and LXR
  Biochemical Society Transactions, 2006
• Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of Type 2 diabetes and atherosclerosis
  Emerging Drugs, 2006
• Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR–α Activators
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
• Peroxisome proliferator-activated receptor α controls cellular cholesterol trafficking in macrophages
  Journal of Lipid Research, 2005
• Therapeutic Roles of Peroxisome Proliferator–Activated Receptor Agonists
  Diabetes, 2005
• PPARs: a new target for neuroprotection
  Journal of Neurology, Neurosurgery & Psychiatry, 2005
• Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function
  Current Opinion in Lipidology, 2003
• Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation
  The Journal of Steroid Biochemistry and Molecular Biology, 2003
• PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
  Nature Medicine, 2001